Literature DB >> 350568

Treatment of multiple intestinal helminthiasis with oxantel and pyrantel.

E G Garcia.   

Abstract

32 elementary school children were treated for multiple intestinal helminthiasis (ascariasis, trichuriasis and hookworm infections) with a combination of the pamoate salts of oxantel and pyrantel in a dose of 15 to 20mg/kg body weight of each in 1 daily dose for 3 consecutive days. The cure rate for ascariasis was 96.7%, and 84.4% for both trichuriasis and hookworm infections. 68.7% were completely cured of all 3 helminths. However, among those not completely cured, only 1 species of the previous 3 infecting helminths was present after treatment and then with a very marked reduction in egg count.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350568     DOI: 10.2165/00003495-197800151-00014

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  5 in total

1.  Treatment for trichuriasis with oxantel.

Authors:  E G Garcia
Journal:  Am J Trop Med Hyg       Date:  1976-11       Impact factor: 2.345

2.  Mebendazole, an effective broad-spectrum anthelmintic.

Authors:  A P Chavarría; J C Swartzwelder; V M Villarejos; R Zeledón
Journal:  Am J Trop Med Hyg       Date:  1973-09       Impact factor: 2.345

3.  Treatment of enterobiasis with pyrantel pamoate.

Authors:  T S Bumbalo; D J Fugazzotto; J V Wyczalek
Journal:  Am J Trop Med Hyg       Date:  1969-01       Impact factor: 2.345

4.  Anthelmintic activity of pyrantel pamoate.

Authors:  R S Desowitz; T Bell; J Williams; R Cardines; M Tamarua
Journal:  Am J Trop Med Hyg       Date:  1970-09       Impact factor: 2.345

5.  Anthelmintic effect of oxantel pamoate and pyrantel pamoate suspension against intestinal nematode infestations.

Authors:  Han Jong Rim; Chang Yong Won; Sung Ik Lee; Jung Kyoo Lim
Journal:  Kisaengchunghak Chapchi       Date:  1975-12
  5 in total
  1 in total

Review 1.  Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review.

Authors:  Marta S Palmeirim; Sabine Specht; Ivan Scandale; Irene Gander-Meisterernst; Monika Chabicovsky; Jennifer Keiser
Journal:  Drugs       Date:  2021-04-30       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.